LMAT Lemaitre Vascular Inc
- Stocks
- Healthcare
- NASDAQ: LMAT
Price (delayed)
$86.27
Market cap
$1.95B
P/E Ratio
41.08
Dividend/share
$0.76
EPS
$2.1
Enterprise value
$2.11B
Relative Growth:
Rel. Growth:
95
Relative Strength:
Rel. Strength:
41
Relative Valuation:
Rel. Valuation:
27
Relative Profitability:
Rel. Profitability:
87
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops,
Highlights
LMAT's net income is up by 25% year-on-year and by 4.3% since the previous quarter
The EPS has grown by 24% YoY and by 4% from the previous quarter
LMAT's quick ratio has soared by 104% YoY but it is down by 15% QoQ
Key stats
What are the main financial stats of LMAT
Market
Valuations
Earnings
Shares outstanding
22.64M
Market cap
$1.95B
Enterprise value
$2.11B
Price to earnings (P/E)
41.08
Price to book (P/B)
5.37
Price to sales (P/S)
8.31
PEG
1.75
EV/EBIT
33.16
EV/EBITDA
28.62
EV/Sales
9
Revenue
$234.64M
Gross profit
$162.16M
Operating income
$54.77M
Net income
$47.12M
EBIT
$63.68M
EBITDA
$73.78M
Free cash flow
$52.32M
Per share
Balance sheet
Liquidity
EPS
$2.1
EPS diluted
$2.05
Free cash flow per share
$2.31
Book value per share
$16.05
Revenue per share
$10.38
TBVPS
$21.16
Total assets
$577.59M
Total liabilities
$214.91M
Debt
$185.89M
Equity
$362.69M
Working capital
$399.31M
Debt to equity
0.51
Current ratio
13.96
Quick ratio
11.55
Net debt/EBITDA
2.15
Margins
Efficiency
Dividend
EBITDA margin
31.4%
Gross margin
69.1%
Net margin
20.1%
Operating margin
23.3%
Return on assets
9.1%
Return on equity
13.7%
Return on invested capital
12.6%
Return on capital employed
11.6%
Return on sales
27.1%
Dividend yield
0.88%
DPS
$0.76
Payout ratio
36.2%
LMAT stock price
How has the Lemaitre Vascular stock price performed over time
Intraday
-1.13%
1 week
-2.93%
1 month
-1.8%
1 year
-12.53%
YTD
-6.37%
QTD
-1.42%
Financial performance
How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$234.64M
Gross profit
$162.16M
Operating income
$54.77M
Net income
$47.12M
Gross margin
69.1%
Net margin
20.1%
LMAT's net income is up by 25% year-on-year and by 4.3% since the previous quarter
The operating income has grown by 20% YoY and by 3.3% from the previous quarter
The company's gross profit rose by 16% YoY and by 4.2% QoQ
Lemaitre Vascular's revenue has increased by 14% YoY and by 3.7% from the previous quarter
Price vs fundamentals
How does LMAT's price correlate with its fundamentals
Growth
What is Lemaitre Vascular's growth rate over time
Valuation
What is Lemaitre Vascular stock price valuation
P/E
41.08
P/B
5.37
P/S
8.31
EV/EBIT
33.16
EV/EBITDA
28.62
EV/Sales
9
The EPS has grown by 24% YoY and by 4% from the previous quarter
The P/E is 9% less than the 5-year quarterly average of 45.0 and 8% less than the last 4 quarters average of 44.5
The equity has grown by 14% YoY and by 4.3% from the previous quarter
LMAT's price to book (P/B) is 10% higher than its 5-year quarterly average of 4.9 but 7% lower than its last 4 quarters average of 5.8
Lemaitre Vascular's revenue has increased by 14% YoY and by 3.7% from the previous quarter
The P/S is 11% above the 5-year quarterly average of 7.5 but 7% below the last 4 quarters average of 8.9
Efficiency
How efficient is Lemaitre Vascular business performance
LMAT's ROIC is down by 46% year-on-year and by 14% since the previous quarter
Lemaitre Vascular's return on assets has decreased by 16% YoY and by 7% QoQ
The ROS has grown by 13% YoY and by 2.7% from the previous quarter
The ROE has grown by 10% YoY
Dividends
What is LMAT's dividend history
DPS
$0.76
Dividend yield
0.88%
Payout ratio
36.2%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Lemaitre Vascular financials performed over time
The company's total assets is 169% higher than its total liabilities
LMAT's quick ratio has soared by 104% YoY but it is down by 15% QoQ
Lemaitre Vascular's current ratio has soared by 67% YoY but it has decreased by 15% from the previous quarter
The company's debt is 49% lower than its equity
The equity has grown by 14% YoY and by 4.3% from the previous quarter
Lemaitre Vascular's debt to equity has decreased by 3.8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.